期刊文献+

羟基喜树碱、平阳霉素、顺铂单独及联合应用对人舌癌细胞活性的影响 被引量:6

Inhibitary effects of hydroxycampothecin, pingyangmycin, cis-platinum or their combination on the human tongue carcinoma cells
暂未订购
导出
摘要 目的 :观察体外应用羟基喜树碱 (HCPT)、平阳霉素 (PYM )、顺铂 (DDP)三种药物单用和两两联合应用对人舌癌Tca8113细胞的生长抑制作用。方法 :采用MTT法、细胞计数法、软琼脂克隆形成法及HE染色法 ,研究用药前后细胞增殖活性及形态的变化。结果 :⑴三种药单用及两药合用对细胞均有很好的抑制作用 ,且以HCPT和PYM合用最强。⑵HCPT和PYM单用和合用可使细胞的群体倍增时间显著延长 ,克隆形成率显著降低 ,形态发生明显的变化。结论 objective: To study the effects of hydroxycampothecin(HCPT), pingyangmycin(PYM), cis platinum (DDP) or their combination on the proliferation of human tongue carcinoma Tca8113 cells. Methods: MTT assay, cell counting,clonogenic assay and HE staining were used to study the effects of HCPT, PYM, DDP or their combination on the proliferation of human tongue carcinoma Tca8113 cells. Results: ①Synergistic inhibiton was observed when HCPT at the concentration (ng/ml) of 10~100 combined with PYM at 32~320 or DDP at 32~320, antagonistic effect was observed when PYM at 32~320 combined with DDP at 32~320; ②After treatment with PYM, HCPT or PYM plus HCPT at IC 30 the clonogenecity (%) of the cells was 15.2, 11.6 and 4.1 respectively, while that of untreated cells 31.7. Conclusion: The combination of HCPT with PYM may be synergistic in the inhibition of tongue carcinoma cell proliferation.
出处 《实用口腔医学杂志》 CAS CSCD 北大核心 2003年第1期54-56,共3页 Journal of Practical Stomatology
关键词 羟基喜树碱 平阳霉素 顺铂 人舌癌 TCA8113细胞 MTT法 Hydroxycampothecin Pingyangmycin Cis platinum Tca8113 cell MTT assay
  • 相关文献

参考文献1

二级参考文献3

共引文献2

同被引文献16

  • 1[3]Chun Ming Tsai,Shu HueiHsiao,Carolin M,et al.Combination cytotoxic effects of cis-diamminedichloroplationum (Ⅱ) and 5-fluorouracil with and without leucovorin against human non-small cell lung cancer cell lines[J].Cancer Reserch,1993,53(1):1079.
  • 2[5]Campos CB,Degasperi GR,Pacffico DS,et al.Ibuprofeninduced Walker 256 tumor cell death:cytochrome c release from functional mitochondria and enhancement by calcineurin inhibition[J].Biochem Pharmacol.2004,68(11):2197-2206.
  • 3[6]Zhang R,Li Y,Cai Q,Liu T,et al.Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin,an inhibitor of topoisomerase I[J].Cancer Chemother Pharmacol,1998,41(4):257-267.
  • 4司徒镇强 吴军正.细胞培养[M].西安:世界图书出版社,2003.66-67.
  • 5Dhaene K,Van Marck E,Pan aresch R.Telomeres.telomerase and cancer:An up date.Virchows Arch,2000,437(1):1.
  • 6Kim NW,Wu F.Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol(TRAP).Nucleic Acide Res,1997,25(6):2595.
  • 7Zhu X,Kumar R,Mandal M,et al.Cell cycle-dependent modulation of telomerase activity in tumor cells.Proc Natl Acad Sci USA, 1996,93(12): 6091.
  • 8Terashima M, Takiyama I, Uesugi N,et al.Telomerase assay as a possible predictor of the response to anticancer chemotherapy.Anticancer Res, 2000,20(1A):293.?A
  • 9Chun Ming Tsai, Shu HueiHsiao, Carolin M, et al. Combination cytotoxic effects of cis - diamminedichloroplationum(Ⅱ) and 5 - fluorouracil with and without leucovorin against human non - small cell 1 ung cancer cell lines [J]. Cancer Res, 1993,53 (1): 1079 .
  • 10Cheng Y, Schneider B, Riese U, et al. Farinosones A - C, neurotrophic alkaloidal metabolites from the entomogenous deuteromycete Paecilomyces farinosus[J]. J Nat Prod. 2004 ,67(11) :1854~1858.

引证文献6

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部